We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Advises Trial Sponsors on Pediatric Applications
EMEA Advises Trial Sponsors on Pediatric Applications
March 18, 2009
Sponsors that plan to conduct a clinical trial among children in the EU should submit a pediatric investigation plan (PIP) letter of intent to the European Medicines Agency (EMEA) Secretariat two months before sending in the complete application.